Androgenetic alopecia
Conditions
Interventions
Treatment group:Microneedle Delivery of a Recombinant Collagen Complex Solution
Sponsors
Yan'an University Xianyang Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1. Clinically diagnosed with androgenetic alopecia and meeting the diagnostic criteria outlined in the *2023 Clinical Practice Guidelines: Diagnosis and Treatment of Androgenetic Alopecia*; 2. Have not used any oral or topical hair loss medications in the past six months; 3. Aged 18–60 years,gender is not restricted; 4. Hair loss is not caused by skin diseases such as leprosy or syphilis, or by trauma or medication; 5. Not currently pregnant or breastfeeding; 6. Willing to sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1. A history of androgenetic alopecia lasting more than 10 years; 2. Having undergone other hair loss treatments within the past 3 months; 3. A history of malignant tumors, platelet dysfunction, anemia, or bleeding disorders; 4. HIV-positive, hepatitis B-positive, or hepatitis C-positive; 5. Impaired immune function; 6. Active skin disease or skin infection in the treatment area; 7. Currently taking nonsteroidal anti-inflammatory drugs (NSAIDs); 8. Tendency to develop keloids.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Hair condition;Effectiveness evaluation; | — |
Secondary
| Measure | Time frame |
|---|---|
| Satisfaction Score;Quality of Life Rating;Scalp symptoms;Safety; | — |
Countries
China
Contacts
Public ContactXiaoyan Chen
Yan'an University Xianyang Hospital
Outcome results
None listed